1. In this updated review of
cancer medications that received
Food and Drug Administration (
FDA) accelerated approval program, only 20% of drugs demonstrate improved overall survival benefit. 2. Final FDA approval was commonly made based on surrogate measures. A substantial proportional of confirmatory trials are still ongoing or delayed despite initial approval. Evidence Rating Level: […]